1
|
McGoldrick LL, Chung JJ. Stopping sperm in their tracks. eLife 2020; 9:55396. [PMID: 32105216 PMCID: PMC7046466 DOI: 10.7554/elife.55396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Accepted: 02/24/2020] [Indexed: 11/13/2022] Open
Abstract
An automated high-throughput platform can screen for molecules that change the motility of sperm cells and their ability to fertilize.
Collapse
Affiliation(s)
- Luke L McGoldrick
- Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, United States
| | - Jean-Ju Chung
- Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, United States.,Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, United States
| |
Collapse
|
2
|
Gruber FS, Johnston ZC, Barratt CLR, Andrews PD. A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity. eLife 2020; 9:e51739. [PMID: 31987071 PMCID: PMC7046468 DOI: 10.7554/elife.51739] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 01/19/2020] [Indexed: 12/14/2022] Open
Abstract
There is an urgent need to develop new methods for male contraception, however a major barrier to drug discovery has been the lack of validated targets and the absence of an effective high-throughput phenotypic screening system. To address this deficit, we developed a fully-automated robotic screening platform that provided quantitative evaluation of compound activity against two key attributes of human sperm function: motility and acrosome reaction. In order to accelerate contraceptive development, we screened the comprehensive collection of 12,000 molecules that make up the ReFRAME repurposing library, comprising nearly all the small molecules that have been approved or have undergone clinical development, or have significant preclinical profiling. We identified several compounds that potently inhibit motility representing either novel drug candidates or routes to target identification. This platform will now allow for major drug discovery programmes that address the critical gap in the contraceptive portfolio as well as uncover novel human sperm biology.
Collapse
Affiliation(s)
- Franz S Gruber
- National Phenotypic Screening Centre, School of Life SciencesUniversity of DundeeDundeeUnited Kingdom
| | - Zoe C Johnston
- National Phenotypic Screening Centre, School of Life SciencesUniversity of DundeeDundeeUnited Kingdom
- Reproductive and Developmental Biology, Division of Systems Medicine, School of MedicineNinewells Hospital and Medical School, University of DundeeDundeeUnited Kingdom
| | - Christopher LR Barratt
- Reproductive and Developmental Biology, Division of Systems Medicine, School of MedicineNinewells Hospital and Medical School, University of DundeeDundeeUnited Kingdom
| | - Paul D Andrews
- National Phenotypic Screening Centre, School of Life SciencesUniversity of DundeeDundeeUnited Kingdom
| |
Collapse
|
3
|
Lecewicz M, Kordan W, Majewska A, Kamiński S, Dziekońska A, Mietelska K. Effects of the platelet-activating factor (PAF) on selected quality parameters of cryopreserved bull semen (AI) with reduced sperm motility. Pol J Vet Sci 2016; 19:147-58. [DOI: 10.1515/pjvs-2016-0019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
The aim of the study was to determine the effects of platelet-activating factor (PAF) on selected quality parameters of cryopreserved bull semen with reduced sperm motility used for artificial insemination. The aim of experiment 1 was to identify the optimal concentration of the phospholipid able to preserve sperm viability. Cryopreserved semen was treated with different PAF concentrations: 1×10-5M, 1×10-6M, 1×10-7M, 1×10-8M and 1×10-9M. The experiment demonstrated that PAF at concentration 1×10-9M increased most the sperm viability parameters (motility parameters, plasma membrane integrity and mitochondrial function) after 120 min of incubation of thawed semen at 37°C. Cryopreserved bull semen with reduced sperm motility (below 70%) was supplemented with PAF in a concentration of 1×10-9M. A statistically significant increase in sperm motility, percentage of linear motile spermatozoa and VSL value was observed after 120 min incubation of sperm with 1×10-9M PAF. Sperm supplementation with PAF also had positive effects on plasma membrane integrity and percentage of spermatozoa with preserved mitochondrial transmembrane potential, but the differences were not statistically significant. The results indicated positive effects of PAF supplementation at a concentration of 1×10-9M on the selected sperm quality parameters in cryopreserved bull semen with reduced motility.
Collapse
|
4
|
Archer SL, Roudebush WE. Enhancement of sperm motility using pentoxifylline and platelet-activating factor. Methods Mol Biol 2013; 927:241-245. [PMID: 22992918 DOI: 10.1007/978-1-62703-038-0_21] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Enhancement of sperm motility can effectively improve assisted reproductive technique outcomes. Here we describe two (pentoxifylline and platelet-activating factor) popular sperm motility enhancers and their respective methods.
Collapse
Affiliation(s)
- Shilo L Archer
- Department of Biology, Charleston Southern University, Charleston, SC, USA
| | | |
Collapse
|
5
|
Treatment of sperm with extracellular adenosine 5'-triphosphate improves the in vitro fertility rate of inbred and genetically modified mice with low fertility. Theriogenology 2011; 76:729-36. [PMID: 21601915 DOI: 10.1016/j.theriogenology.2011.04.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2011] [Revised: 04/01/2011] [Accepted: 04/03/2011] [Indexed: 11/22/2022]
Abstract
In vitro fertilization (IVF) is one of the most important techniques used for assisted reproduction in mouse colony management. As with natural mating, where mice have varying fertility indices, fertility rates of genetically modified (GM) [transgenic (Tg), knock out (KO) and congenic (Cg)] mice are influenced by their genetic background. Lines of GM mice that have poor fertility have a concomitant poor IVF outcome. Treatment of mouse sperm with extracellular adenosine 5'-triphosphate (ATPe) enhanced in vitro fertilization rates in outbred and hybrid mice. The objective of this study was to analyze the effects of using extracellular adenosine 5'-triphosphate-treated sperm for IVF of inbred wild type, and genetically modified mouse lines, for which standard IVF did not work well. The IVF was performed using the GM mice on C57BL/10SnJ, C57BL/6J, BALB/cJ and NFS/N background strains and wild type (WT) mice such as C57BL/6N, BALB/cAnN, and B6129SF1 strains. Oocytes from superovulated females were fertilized in vitro with sperm from the same background strain, and either treated or not treated with ATPe. The ATPe treatment enhanced IVF outcome in most of the GM and some WT strains, as indicated by the percentage of embryos that progressed to the two-cell stage. There was no marked difference between ATPe treated and control groups for the development rate of two-cell embryos to blastocysts in culture, or in the number of pups born after transfer of two-cell embryos into recipient females. The observed improvement of the IVF results following ATPe treatment of transgenic and KO mouse sperm were a potential solution for improving the outcome of assisted reproduction techniques used for rederivation or for gamete banking.
Collapse
|
6
|
Grassi G, Cappello N, Gheorghe MF, Salton L, Di Bisceglie C, Manieri C, Benedetto C. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. J Endocrinol Invest 2010; 33:684-90. [PMID: 20220291 DOI: 10.1007/bf03346670] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The objective of this study is to determine the optimal conditions for human semen incubation treated with exogenous platelet activating factor (ePAF) for intra-uterine insemination (IUI). This prospective study was carried out on 32 infertile men and each semen sample was processed with the ISolate Sperm Separation Medium, washed with sperm washing medium (SWM) and resuspended either in SWM alone (control samples), or with ePAF 0.1, 0.5, and 1.0 μM. Each concentration was subsequently incubated and evaluated at 5, 15, 30, and 60 min. The motility parameters were evaluated by the computer-aided sperm analysis (C.A.S.A.) system. Curvilinear velocity, straight line velocity, average path velocity, rapid and progressive motility significantly increased compared to control samples at an ePAF concentration of 0.1 μM (with at least 15 min of incubation). The best results were obtained with ePAF concentrations of: 0.1 μM (60 min of incubation) and 0.5 μM (30-60 min of incubation). In conclusion, results are enhanced when ePAF is added to standard semen preparation for IUI. An ePAF concentration of 0.1 μM, with an incubation time of 15 min, can be used for semen samples with normal motility. Whilst, for semen samples with poor motility, the ePAF concentration is best increased to 0.5 μM and/or the incubation time prolonged to 60 min.
Collapse
Affiliation(s)
- G Grassi
- Department of Obstetrics and Gynaecology, University of Turin, Via Ventimiglia 3, 10126, Turin, Italy.
| | | | | | | | | | | | | |
Collapse
|
7
|
Baka S, Grigoriou O, Hassiakos D, Konidaris S, Papadias K, Makrakis E. Treatment of Sperm With Platelet-activating Factor Does Not Improve Intrauterine Insemination Outcome in Unselected Cases of Mild Male Factor Infertility: A Prospective Double-blind Randomized Crossover Study. Urology 2009; 74:1025-8. [DOI: 10.1016/j.urology.2009.06.023] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2009] [Revised: 05/19/2009] [Accepted: 06/02/2009] [Indexed: 11/16/2022]
|
8
|
Ombelet W, Campo R, Bosmans E, Nijs M. Intrauterine insemination (IUI) as a first-line treatment in developing countries and methodological aspects that might influence IUI success. ACTA ACUST UNITED AC 2008. [DOI: 10.1093/humrep/den165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
9
|
Edwards SE, Buffone MG, Knee GR, Rossato M, Bonanni G, Masiero S, Ferasin S, Gerton GL, Moss SB, Williams CJ. Effects of extracellular adenosine 5'-triphosphate on human sperm motility. Reprod Sci 2008; 14:655-66. [PMID: 18000227 DOI: 10.1177/1933719107306227] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Extracellular adenosine 5'-triphosphate (ATP) previously has been shown to increase the fertilization percentage in human in vitro fertilization (IVF) performed for male factor infertility. The objective of this study is to determine the effects of extracellular adenosine 5'-triphosphate (ATPe) on human sperm function by examining its effects on end points of sperm capacitation. Sperm obtained from healthy volunteers with normal semen parameters, asthenozoospermic men, and cryopreserved samples were incubated in medium with or without 2.5 mM ATPe. The effects of ATPe on acrosomal exocytosis, protein tyrosine phosphorylation, and sperm motility parameters were quantified. Although ATPe did not affect acrosomal exocytosis or protein tyrosine phosphorylation in sperm from healthy donors, it significantly altered several motility parameters, with the largest effects manifested in increased curvilinear velocity and percentage hyperactivation. ATPe similarly affected sperm selected for poor motility and thawed cryopreserved sperm but to a lesser extent than its effects on sperm with normal motility. ATPe increased straight-line velocity and linearity of sperm obtained from asthenozoospermic men. Human sperm motility characteristics are altered by ATPe; this finding may explain its previously reported beneficial effect on human IVF. These results suggest that ATPe could constitute a new therapeutic modality in the treatment of male infertility.
Collapse
Affiliation(s)
- Scott E Edwards
- Center for Research on Reproduction & Women's Health, Department of Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, PA, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Contribution of sperm molecular features to embryo quality and assisted reproduction success. Reprod Biomed Online 2008; 17:855-65. [DOI: 10.1016/s1472-6483(10)60415-4] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
11
|
Ali A, Virirak Kattygnarath T, Benkhalifa M, Miron P. Essential role of platelet-activating factor in male reproduction: a review. Reprod Biomed Online 2007; 14:250-5. [PMID: 17298732 DOI: 10.1016/s1472-6483(10)60795-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The use of pharmacological adjuvants to enhance sperm function is a real possibility and a very attractive proposition. However, the role of such adjuvants must be well defined to maximize therapeutic outcome for specific patient populations. Platelet-activating factor (PAF) is a potent signalling phospholipid that has been implicated in a number of biological activities. In the field of reproductive biology, PAF has been shown to have an important role in ovulation, sperm function, embryo implantation, fetal lung maturation, and initiation and maintenance of parturition. Although the exact mechanisms are not clear, it has been demonstrated in several species that PAF can influence sperm function by affecting the motility, capacitation, acrosome reaction and fertility of spermatozoa. The reproductive significance of PAF activity in spermatozoa and fertilization and its role in the establishment of pregnancy requires further study. Understanding the role of PAF in a reproductive process, such as in intrauterine insemination, could eventually lead researchers to explore its role in more complex reproductive technologies. This review summarizes the current research on the significant role of PAF in male mammalian reproductive functions, as well as its possible application in some assisted reproductive technologies.
Collapse
Affiliation(s)
- Atef Ali
- Centre de Fertilité et de Reproduction FERTILYS, Laval, Québec, Canada
| | | | | | | |
Collapse
|
12
|
Bathgate R, Maxwell WMC, Evans G. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. Theriogenology 2006; 67:886-92. [PMID: 17157372 DOI: 10.1016/j.theriogenology.2006.09.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2006] [Accepted: 09/24/2006] [Indexed: 10/23/2022]
Abstract
Cryopreservation of boar sperm compromises fertility after thawing by reducing sperm longevity and inducing acrosome reaction-like changes. In an attempt to improve the post-thaw motility and acrosome integrity of boar sperm, semen was frozen using a modified Westendorf method in which the medium was supplemented with either platelet-activating factor (PAF) or a recombinant platelet-activating factor:acetylhydrolase (PAF:AH; Pafase) before or after freezing. Platelet-activating factor is a phospholipid that is present in boar semen and PAF:AH is the naturally occurring enzyme that converts PAF to biologically inactive Lyso-PAF. Addition of PAF to the cryopreservation medium improved post-thaw motility immediately after thawing and after 3h incubation at 37 degrees C (60.0+/-0.0% and 25.0+/-2.9%; mean+/-S.E.M.) compared to the control sperm (41.7+/-1.7% and 10.0+/-2.9%; P<0.05). Acrosome integrity was higher immediately after thawing and after 3 and 6h incubation at 37 degrees C when sperm were frozen in the presence of Pafase (55.7+/-3.2%, 45.7+/-3.7% and 23.0+/-3.1%), compared to the control sperm (42.7+/-1.5%, 25.7+/-5.7% and 12.3+/-2.7%) and sperm frozen in the presence of PAF (33.0+/-3.7%, 26.3+/-2.2% and 11.7+/-0.3%; P<0.05). Addition of PAF to sperm after thawing improved motility immediately post-thaw (41.6+/-2.6%), compared with addition of Pafase (23.3+/-2.2%) or the control sperm with no supplementation of the medium (26.7+/-2.2%; P<0.05). However, this beneficial effect was lost by 3h post-thaw. Supplementation of boar semen cryopreservation medium with PAF and Pafase appeared to have beneficial effects on the in vitro quality of the sperm post-thaw.
Collapse
Affiliation(s)
- R Bathgate
- Centre for Advanced Technologies in Animal Genetics and Reproduction (ReproGen), Faculty of Veterinary Science, The University of Sydney, NSW 2006, Australia.
| | | | | |
Collapse
|
13
|
Zhu J, Massey JB, Mitchell-Leef D, Elsner CW, Kort HI, Roudebush WE. Platelet-activating factor acetylhydrolase activity affects sperm motility and serves as a decapacitation factor. Fertil Steril 2006; 85:391-4. [PMID: 16595216 DOI: 10.1016/j.fertnstert.2005.07.1303] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2005] [Revised: 07/19/2005] [Accepted: 07/19/2005] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To determine the relationship between platelet-activating factor acetylhydrolase (PAFah) content in semen and sperm motility. DESIGN The PAFah levels in semen were measured and correlated with sperm motility. SETTING Clinical laboratory in a private assistant reproductive technology clinic. PATIENT(S) Three hundred and twelve men seeking diagnosis and treatment of infertility. INTERVENTION(S) Semen samples were collected from 312 healthy mature men seeking infertility treatment. Sperm motility and PAFah activity were measured in seminal plasma. Data was analyzed by Student's t test and regression analysis. MAIN OUTCOME MEASURE(S) PAFah activity and sperm motility. RESULT(S) Seminal PAFah content ranged from a low of 179 IU/L to a high of 2,457 IU/L. The overall mean PAFah content in semen was 780.59 IU/L. Linear regression analysis revealed a significant (R2 = 0.655) and negative relationship between PAFah content in semen and sperm motility. Semen specimens with high percent motility (> or = 50%) had significantly lower PAFah concentrations (442.03 +/- 14.37 IU/L) than those with the lower percent sperm motility (< 50%) (882.16 +/- 18.45 IU/L). CONCLUSION(S) The data confirm the presence of PAFah in human semen and that activity is significantly and negatively correlated with sperm motility. The PAFah is proven to be a candidate for sperm decapacitation factors, whereas PAF is qualified to be a candidate for sperm capacitation factors.
Collapse
Affiliation(s)
- Jiuming Zhu
- Reproductive Biology Associates, Atlanta, Georgia 30342, USA.
| | | | | | | | | | | |
Collapse
|
14
|
Roudebush WE, Massey JB, Elsner CW, Shapiro DB, Mitchell-Leef D, Kort HI. The significance of platelet-activating factor and fertility in the male primate: a review. J Med Primatol 2005; 34:20-4. [PMID: 15667340 DOI: 10.1111/j.1600-0684.2004.00087.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Since its discovery nearly 30 years ago platelet-activating factor (PAF) has emerged as one of the more important lipid mediators known. PAF (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphorylcholine) exists endogenously as a mixture of molecular species with structural variants of the alkyl moiety. PAF is a novel potent signaling phospholipid that has unique pleiotropic biological properties in addition to platelet activation. PAF also plays a significant role in reproduction and is present in the sperm of a number of primate species. PAF content in squirrel monkey sperm is significantly higher during the breeding season than the non-breeding season. PAF content in rhesus sperm has a significant relationship with sperm motility. PAF content in human sperm has a positive correlation with seminal parameters and pregnancy outcomes. The enzymes (lyso-PAF-acetyltransferase and PAF-acetylhydrolase) necessary for PAF activation and deactivation are present in primate sperm. PAF-acetylhydrolase may act as a "decapacitation factor". Removal of this enzyme during capacitation promotes PAF synthesis increasing primate motility and fertilization. PAF also plays a significant role in the fertilization process, enhancing the fertilization rates of oocytes. Enhanced embryo development has also been reported in oocytes fertilized with PAF-treated sperm. Exogenous PAF will also significantly improve primate artificial insemination pregnancy outcomes. PAF antagonists inhibit sperm motility, acrosome reaction, and fertilization thus suggesting the presence of receptors for PAF. The PAF-receptor is present on primate sperm, with altered transcript levels and distribution patterns on abnormal cells. Whereas, the exact mechanism of PAF in sperm function and reproduction is uncertain, its importance in normal primate fertility is substantial.
Collapse
Affiliation(s)
- William E Roudebush
- Reproductive Biology Associates, 1150 Lake Hearn Drive, Suite 400, Atlanta, GA 30342, USA.
| | | | | | | | | | | |
Collapse
|